ROIVANT SCIENCES LTD ($ROIV)

2 tracked superinvestors hold ROIVANT SCIENCES LTD (ROIV), worth $244M combined, led by Andreas Halvorsen. Smart money is holding ROIV as of the latest 13F filings.

Current price

$36.81

BiotechnologyNASDAQGB

+210.9%

1Y

Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne, myasthenia gravis, warm autoimmune hemolytic…

Market cap

$19.9B

P/E

-23.79

Div yield

0.0%

Revenue YoY

-71.6%

Analyst target

$37

Snapshot for context. For deep analysis use a stock screener — this page is about who owns it.

Superinvestors holding

2

tracked 13F / N-PORT funds

Combined value

$244M

disclosed long exposure

Tier-1 conviction

2

concentrated holders

Net this quarter

0

0 buying · 0 selling

Smart money is holding ROIV steady this quarter — buys and sells are balanced.

The smart-money take on ROIV

ROIVANT SCIENCES LTD (ROIV) is held by 2 tracked funds worth $244M combined, 2 of them concentrated Tier-1 managers whose positions carry real conviction.

The largest position belongs to Andreas Halvorsen at 0.5% of their book — no single tracked manager treats it as an outsized, top-weighted bet.

Tracked holders were largely static this quarter — no new opens, adds or trims of size — suggesting the position is being held rather than actively traded.

Superinvestors holding ROIV

InvestorMove% of their portfolioPosition value
1
Andreas Halvorsen

Viking Global Investors

Held0.5%$184M
1
David Einhorn

Greenlight Capital

Held1.9%$60M

Tier badge = signal quality: 1 concentrated conviction · 2 quant/multi (context) · 3 retail & diversified. Only Tier 1 holdings feed the consensus signal.

Frequently asked

Which superinvestors own ROIV?

2 tracked funds hold ROIVANT SCIENCES LTD (ROIV), the largest being Andreas Halvorsen (Viking Global Investors) at 0.5% of its 13F portfolio. 2 of them are concentrated Tier-1 conviction managers.

Is smart money buying or selling ROIV?

In the most recent 13F quarter, 0 tracked funds added or opened ROIV and 0 trimmed it.

How much ROIV do tracked funds hold?

Combined disclosed long exposure to ROIV across tracked superinvestors is $244M as of the Mar 2026 filings.

Stocks often held alongside ROIV

Holdings aggregated from the latest SEC 13F & N-PORT filings via FMP · Mar 2026 quarter. Long equity positions only, reported with up to a 45-day delay — for activity between filings see real-time moves. Not financial advice.